Biologics Quality Control Testing
PathoQuest, a spin-out of Institut Pasteur Paris, is a genomics expert company offering a game-changing next-generation sequencing (NGS) approach for microbiology testing.
The NGS-based technology the company has developed is used for:
• The quality control (QC) testing of biologicals (e.g., ATMP, vaccines, antibodies), enabling rapid and robust analysis at a GMP level
PathoQuest’s technology leverages the company’s proprietary sample preparation protocols, which are applicable to several types of biological samples, proprietary internally-curated pathogen genome databases, and automated analysis pipelines.
Oxford Nanopore and PathoQuest announce the first steps in a strategic collaboration to bring the first GMP-accredited, nanopore-based biologics genetic characterisation test to market
Press Release Nanopore sequencing offers a...
PathoQuest Reiterates its Strategic Growth Plans by Appointing Daniel Spasic to the Board
News ReleaseDaniel Spasic, a highly experienced...
The updated ICH Q5A(R2) draft guidance has been released
News ReleasePathoQuest, a leader in the...
Let’s Start Something New
Welcome to PathoQuest!